GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diagnosticos da America SA (BSP:DASA3) » Definitions » Beneish M-Score

Diagnosticos da America (BSP:DASA3) Beneish M-Score : -2.52 (As of Mar. 29, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Diagnosticos da America Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.52 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Diagnosticos da America's Beneish M-Score or its related term are showing as below:

BSP:DASA3' s Beneish M-Score Range Over the Past 10 Years
Min: -3.27   Med: -2.63   Max: -1.98
Current: -2.52

During the past 13 years, the highest Beneish M-Score of Diagnosticos da America was -1.98. The lowest was -3.27. And the median was -2.63.


Diagnosticos da America Beneish M-Score Historical Data

The historical data trend for Diagnosticos da America's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnosticos da America Beneish M-Score Chart

Diagnosticos da America Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.98 -2.48 -2.18 -2.52 -2.52

Diagnosticos da America Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.52 -2.70 -2.63 -2.50 -2.52

Competitive Comparison of Diagnosticos da America's Beneish M-Score

For the Diagnostics & Research subindustry, Diagnosticos da America's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnosticos da America's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diagnosticos da America's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Diagnosticos da America's Beneish M-Score falls into.


;
;

Diagnosticos da America Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Diagnosticos da America for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.158+0.528 * 0.9965+0.404 * 0.9409+0.892 * 1.0751+0.115 * 0.922
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9987+4.679 * -0.046372-0.327 * 0.9891
=-2.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was R$4,951 Mil.
Revenue was 3669.185 + 3969.21 + 3955.692 + 3727.992 = R$15,322 Mil.
Gross Profit was 846.133 + 1141.817 + 1139.81 + 1065.488 = R$4,193 Mil.
Total Current Assets was R$8,203 Mil.
Total Assets was R$26,458 Mil.
Property, Plant and Equipment(Net PPE) was R$6,192 Mil.
Depreciation, Depletion and Amortization(DDA) was R$1,367 Mil.
Selling, General, & Admin. Expense(SGA) was R$3,194 Mil.
Total Current Liabilities was R$5,299 Mil.
Long-Term Debt & Capital Lease Obligation was R$11,712 Mil.
Net Income was -830.923 + -87.489 + -104.623 + -175.955 = R$-1,199 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = R$0 Mil.
Cash Flow from Operations was 222.815 + 226.652 + -264.03 + -157.491 = R$28 Mil.
Total Receivables was R$3,977 Mil.
Revenue was 3318.212 + 3769.014 + 3630.94 + 3534.07 = R$14,252 Mil.
Gross Profit was 638.276 + 1113.712 + 1084.466 + 1050.546 = R$3,887 Mil.
Total Current Assets was R$7,032 Mil.
Total Assets was R$26,213 Mil.
Property, Plant and Equipment(Net PPE) was R$6,479 Mil.
Depreciation, Depletion and Amortization(DDA) was R$1,296 Mil.
Selling, General, & Admin. Expense(SGA) was R$2,975 Mil.
Total Current Liabilities was R$5,641 Mil.
Long-Term Debt & Capital Lease Obligation was R$11,397 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(4950.821 / 15322.079) / (3976.643 / 14252.236)
=0.323117 / 0.279019
=1.158

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(3887 / 14252.236) / (4193.248 / 15322.079)
=0.272729 / 0.273674
=0.9965

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (8203.062 + 6191.95) / 26458.471) / (1 - (7031.514 + 6478.93) / 26213.2)
=0.455939 / 0.484594
=0.9409

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=15322.079 / 14252.236
=1.0751

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1296.305 / (1296.305 + 6478.93)) / (1366.818 / (1366.818 + 6191.95))
=0.166722 / 0.180825
=0.922

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(3194.343 / 15322.079) / (2975.303 / 14252.236)
=0.20848 / 0.20876
=0.9987

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((11712.152 + 5299.051) / 26458.471) / ((11397.234 + 5641.375) / 26213.2)
=0.64294 / 0.650001
=0.9891

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-1198.99 - 0 - 27.946) / 26458.471
=-0.046372

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Diagnosticos da America has a M-score of -2.52 suggests that the company is unlikely to be a manipulator.


Diagnosticos da America Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Diagnosticos da America's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnosticos da America Business Description

Traded in Other Exchanges
N/A
Address
Avenida Jurua, 434, Alphaville, Barueri, SP, BRA, 06455-010
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).

Diagnosticos da America Headlines

No Headlines